Effect of antimicrobial therapy on progression free survival of immunotherapy and chemo-/ immunotherapy in patients with NSCLC.

被引：0
|
作者：
Uhlenbruch, M. [1 ]
Krueger, S. [1 ]
机构：
[1] Florence Nightingale Krankenhaus Dusseldorf, Klin Pneumol Kardiol Internist Intensivmed, Dusseldorf, Germany
来源：
PNEUMOLOGIE | 2024年 / 78卷
关键词：
D O I：
10.1055/s-0044-1778946
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
FV 27
引用
收藏
页码：S97 / S98
页数：2
相关论文
共 50 条
  • [1] Effect of antimicrobial therapy on progression-free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer
    Mark Uhlenbruch
    Stefan Krüger
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5915 - 5919
  • [2] Effect of antimicrobial therapy on progression-free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer
    Uhlenbruch, Mark
    Krueger, Stefan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (09) : 5915 - 5919
  • [3] Effect of TTF-1 expression on progression free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer
    Uhlenbruch, Mark
    Krueger, Stefan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (08)
  • [4] Thromboembolism (TE) and association with survival in patients (pts) with melanoma receiving chemo- or immunotherapy.
    Sussman, Tamara A.
    Vu, Long
    Buchbinder, Elizabeth Iannotti
    Ott, Patrick Alexander
    Markt, Sarah C.
    Koroukian, Siran M.
    Hodi, F. Stephen
    Khorana, Alok A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Neoadjuvant chemo-immunotherapy increases tumor immune lymphocytes infiltration in resectable NSCLC.
    Li, Ziming
    Chen, Tianxiang
    Wen, Fengcai
    Zhang, Ding
    Chen, Yanan
    Zhao, Xiaochen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC.
    Sands, Jacob
    Mandrekar, Sumithra J.
    Oxnard, Geoffrey R.
    Kozono, David E.
    Hillman, Shauna L.
    Dahlberg, Suzanne Eleanor
    Sun, Zhuoxin
    Chaft, Jamie E.
    Govindan, Ramaswamy
    Gerber, David E.
    Gray, Jhanelle Elaine
    Malik, Shakun M.
    Mooney, Margaret M.
    Janne, Pasi A.
    Vokes, Everett E.
    Kelly, Karen
    Ramalingam, Suresh S.
    Stinchcombe, Tom
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Lymphocyte Count Pre-immunotherapy Predicts Progression-Free Survival in Stage III NSCLC Treated with Chemoradiotherapy and Immunotherapy
    Abravan, A.
    Horne, A.
    van Herk, M.
    Price, G.
    Faivre-Finn, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S567 - S567
  • [8] New Guideline Recommendations on Chemo- and Immunotherapy for Patients with metastatic Urothelial Carcinoma
    Mugele, Katrin
    Gromes, Angelina
    Wahlers, Bettina-Cathrin
    UROLOGE, 2020, 59 (07): : 871 - 872
  • [9] Effect of SBRT plus immunotherapy on immune status and survival quality of NSCLC patients: A study of combined radiotherapy and immunotherapy
    Shao, Liang
    Gao, Ying
    Zhang, Dan
    Yang, Mengdan
    Jiang, Mimi
    Li, Hongfeng
    Yan, Yanting
    TECHNOLOGY AND HEALTH CARE, 2025, 33 (01) : 485 - 494
  • [10] Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy
    Puntigam, Lisa K.
    Jeske, Sandra S.
    Goetz, Marlies
    Greiner, Jochen
    Laban, Simon
    Theodoraki, Marie-Nicole
    Doescher, Johannes
    Weissinger, Stephanie E.
    Brunner, Cornelia
    Hoffmann, Thomas K.
    Schuler, Patrick J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 17
12345